Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Spring 2025 - Safety
Download Issue
Share
Up Front
Publisher's Corner
Honest, Empathetic Rapport Builds Patient Trust
By Patrick M. Schmidt
Features
Navigating the Medical Misinformation Age
By
Trudie Mitschang
Decatastrophizing Patient Fears
By
Meredith Whitmore
Myths & Facts: GLP-1 Drugs for Weight Loss
By
Ronale Tucker Rhodes, MS
Diagnosing and Treating Infant Botulism
By
Ronale Tucker Rhodes, MS
Update on Rabies
By
Jim Trageser
BioTrends Watch
Washington Report
CMS Releases Proposed 2026 Payment Policy Updates for MA and Part D Programs
HHS Announces 15 Additional Drugs for Price Negotiations
Grant Allows UCLA to Launch Autoimmunity Center to Find Cures
Grant Awarded to Accelerate Pandemic Influenza mRNA Vaccine Development
Reimbursement FAQs
Payment Complexity Demands Data Integrity
Healthcare Management
Creating a Cybersecurity and Incidence Response Strategy for Small Offices
Industry News
Grifols Receives $21M to Study Parkinson's Plasma Samples
Common Virus May Cause a Type of Alzheimer's
Blood Test Can Predict How Long Vaccine Immunity Will Last
Triglyceride Drug Approved to Treat Adults with FCS
Coupling HA Molecules from Various Flu Strains Could Make Vaccines More Effective
FDA Approves Chikungunya Vaccine
GSK's Penmenvy Meningococcal Vaccine Approved by FDA
FDA Approves New Medication for Acute Pain
RSV Vaccine Prompts Robust Response in Older Recipients
Multiple Myeloma Patients Treated with Teclistamab May Benefit from IVIG Supplementation
New Biosimilar Autoimmune Disease Treatment Approved by FDA
FDA Approves Zepbound to Treat Obstructive Sleep Apnea
BioFocus
Industry Insight
New and Better Hemophilia A Treatment Options Just Keep Coming
By Keith Berman, MPH, MBA
Patient Profile
Infant Botulism: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Infant Botulism: A Physician's Perspective
By Trudie Mitschang
BioSources
BioTech
Smart Tools for Patient Safety